Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host-Microbiome-Metabolomic Signatures.

J Crohns Colitis · 2025 · PMC11831226 · PMID 39673746

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

At Week 8, following withdrawal of OV, a nonsignificant trend toward an increase in serum ALT and ALP values was observed compared with Week 4 ( Figure 2 , B ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.